CellSource CoTSE:4880 -2.15%69 OCF Margin % is 16.21% as of Apr. 2026, which is 9% below its 10-year median of 17.80. GuruFocus rates TSE:4880 with a GF Score™ of 69/100 and a GF Value™ of 円781.48 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 948 Biotechnology companies, CellSource Co ranks better than 77.53% on this metric.
The historical rank and industry rank for CellSource Co's OCF Margin % or its related term are showing as below:
TSE:4880'
s OCF Margin % Range Over the Past 10 Years
Min: 8.97 Med: 17.8 Max: 30.74
Current: 12.17
During the past 9 years, the highest OCF Margin % of CellSource Co was 30.74%. The lowest was 8.97%. And the median was 17.80%.
TSE:4880's OCF Margin % is ranked better than 77.53% of 948
companies
in the Biotechnology industry
Industry Median: -64.115
vs TSE:4880: 12.17
CellSource Co OCF Margin % Related Terms
CellSource Co OCF Margin % Historical Data
* Premium members only.
The historical data trend for CellSource Co's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4880 vs VRTX, REGN, ALNY: OCF Margin % Comparison
For the Biotechnology subindustry, CellSource Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CellSource Co OCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, CellSource Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where CellSource Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CellSource Co (TSE:4880) has a OCF Margin % of 16.21% as of Apr. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on CellSource Co and its competitors. This is near median its historical median of 17.80. Over the past decade, CellSource Co's OCF Margin % has ranged from 8.97 to 30.74. According to the industry distribution chart, CellSource Co ranks #213 out of 948 companies in the Biotechnology industry, placing it in the top 22.5%.
Is CellSource Co's OCF Margin % too high?
CellSource Co's current OCF Margin % of 16.21% is near median its 10-year median of 17.80. Over the past 10 years, this metric has ranged from a low of 8.97 to a high of 30.74. Based on the distribution chart, CellSource Co ranks #213 out of 948 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, CellSource Co has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CellSource Co's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, CellSource Co ranks #213 out of 948 companies for OCF Margin %. This places CellSource Co in the top 23% of its industry — outperforming the majority of peers. Historically, CellSource Co's own OCF Margin % has ranged from 8.97 to 30.74 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on CellSource Co and its competitors. CellSource Co's current OCF Margin % is 16.21%, which is near median its own 10-year median of 17.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CellSource Co stock overvalued right now?
Based on GuruFocus' analysis, CellSource Co (TSE:4880) is currently considered Significantly Undervalued. The stock's GF Value™ is 円781.48, compared to a current price of 円319.00 — trading 59.2% below its estimated fair value. The current OCF Margin % is 16.21%, which is near median its 10-year median of 17.80. CellSource Co's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For CellSource Co (TSE:4880), the current OCF Margin % is 16.21% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CellSource Co (TSE:4880) Overvalued in 2026?
Based on GuruFocus' analysis, CellSource Co stock appears to be undervalued.
The current stock price of 円319.00 is trading 59.2% below its estimated GF Value™ of 円781.48.
GuruFocus considers CellSource Co to be Significantly Undervalued.
Key valuation signals for TSE:4880:
OCF Margin %: 16.21% (near median its 10-year median of 17.80)
GF Value™: 円781.48 vs. price of 円319.00 (59.2% below fair value)
No single metric tells the full story. See the TSE:4880 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CellSource Co Ltd is engaged in contract manufacturing of fat-and blood-derived organizations and cells from medical institutions, provision of legal support to medical institutions in the regenerative medicine business. The company is also involved in sales of medical devices, and sales of own-brand cosmetics in the consumer business.
69GF Score
Get the complete analysis for TSE:4880
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4880 has been successfully added to your 
